Cancer Anorexia: The Unmet Need
(Learn more about Artelo’s ART27.13 Program)
An Overview of ART26.12, Artelo’s FABP5 Inhibitor Program for Breast and Prostate Cancers
ART12.11: The advantages of a CBD Cocrystal
Jun 29, 2022
Artelo CSO Andy Yates, PhD, joins the Huxley Morton Podcast
May 3, 2022
Artelo CEO Greg Gorgas presents at the at the Q2 Investor Summit in NYC
Mar 28, 2022
Artelo CEO Greg Gorgas joins The Big Biz Show hosted by Bob “Sully” Sullivan
Sep 7, 2021
Benzinga Power Hour interview with Greg Gorgas, CEO of Artelo Biosciences
Jul 28, 2021
R&D Showcase: ART27.13 in Cancer Anorexia (Click to Watch)
Oct 28, 2020
Artelo CEO Greg Gorgas speaks with Don Yocham at The National Institute of Cannabis Investing (Click to Watch)